恒瑞医药(01276)拟回购10亿-20亿元的A股股份

Core Viewpoint - Heng Rui Medicine (01276) announced a share buyback plan to enhance employee motivation and protect investor interests, reflecting confidence in the company's future development prospects and fundamentals [1] Summary by Categories Company Actions - The company plans to repurchase its A-shares using its own funds, with a total amount not less than RMB 1 billion and not exceeding RMB 2 billion [1] - The repurchase price will not exceed RMB 90.85 per share [1] - The repurchased shares will be used for the A-share employee stock ownership plan [1]